U-937

Information for U-937

Description

Human histiocytic lymphoma established from the pleural effusion of a 37-year-old man with generalized diffuse histiocytic lymphoma in 1974. Cells were described to express markers and properties of monocytes; Human leukemic monocyte lymphoma cell line.

Source BRENDA Tissue Ontology (BTO)

ReMap Statistics

Datasets
11
Transcriptional Factors
9
Peaks
175,616
Non-redundant peaks
148,570

Description

Cell_name
U-937
Category
Cancer cell line
Disease
NCIt; C8263; Adult acute monocytic leukemia
Sex_gender_of_cell
Male
Age_of_donor
37Y

External IDs

Cellosaurus
CVCL_0007
Experimental Factor
EFO_0001257
BRENDA Tissue
BTO:0001412
Wiki
U-937
ATCC
U-937
Synonyms
U 937; U937
All peaks U-937
Download BED file
Non redundant U-937
Download BED file
CRMs U-937
Download BED file
DOWNLOAD All ReMap
Go to catalogue

Datasets Table for U-937

Biotype Biotype modification Ecotype Target name Target modification Source Species Experiment Peaks
U-937 CEBPA ENA Homo sapiens ERP008568 Download (29,126)
U-937 CTCF ENA Homo sapiens ERP008568 Download (13,522)
U-937 SMC3 ENA Homo sapiens ERP008568 Download (77)
U-937 SPI1 ENA Homo sapiens ERP008568 Download (104,872)
U-937 STAG1 ENA Homo sapiens ERP008568 Download (11,130)
U-937 RBP2 L GEO Homo sapiens GSE28323 Download (469)
U-937 RBP2 GEO Homo sapiens GSE28323 Download (2,199)
U-937 RUNX1 GEO Homo sapiens GSE65427 Download (9,411)
U-937 ATRA-treated_MYB MYB GEO Homo sapiens GSE98006 Download (447)
U-937 vehicle-treated_MYB MYB GEO Homo sapiens GSE98006 Download (1,488)
U-937 ATRA-treated_RAR RARA GEO Homo sapiens GSE98006 Download (2,875)
Biotype Biotype modification Ecotype Target name Target modification Source Species Experiment Peaks

ReMap is a database of transcriptional regulators peaks derived from curated ChIP-seq, ChIP-exo, DAP-seq experiments in Human and Thaliana.

You are using the 2020 ReMap (3rd) release.
The ReMap catalogues (2020, 2018, 2015) are under CC BY-NC 4.0 international license, while ReMapEnrich, remap-pipeline under GNU GPLv3 licence.

Inserm TAGC
AMU AMU-MESO

This work was granted access to the HPC resources of Aix-Marseille Université financed by the project Equip@Meso (ANR-10-EQPX-29-01) of the program "Investissements d’Avenir" supervised by the Agence Nationale de la Recherche.